NEW YORK (CNNMoney.com) -- The Food and Drug Administration has hit another Johnson & Johnson unit -- medical device maker DePuy Orthopaedics -- with a warning letter for selling hip and other joint products without the agency's approval.
The FDA said in the letter that the company has been selling its TruMatch Personalized Solutions System, which makes artificial knee products, and the Corail Hip System without "market clearance" and in violation of the Federal Food, Drug, and Cosmetic Act.
The agency said DePuy should immediately stop selling the Corail products or face further enforcement action, which could include product seizure, injunction or civil penalties.
The FDA said it will only evaluate whether these products can be legally marketed to consumers after DePuy submits information for approval.
The company's McNeil Consumer Healthcare unit, which makes well-known cold and pain drugs such as Tylenol and Benadryl, has received negative inspection reports and warning letters tied to manufacturing lapses at its U.S. factories.
In May, McNeil shut a plant in Fort Washington, Penn., after the company recalled millions of children's Tylenol and other drugs that were made at that facility.
In this latest warning letter, the FDA has given Depuy 15 days to correct the violations.
New McDonald's CEO Steve Easterbrook promised sirloin burgers and artisan grilled chicken sandwiches. More
The U.S. economy and markets have been flat this year. More
Some people shelled out $100 to watch Floyd Mayweather vs Manny Pacquiao fight on pay-per-view. Others simply went online and watched it for free on Periscope or Meerkat. More
The financial costs and perks of getting hitched aren't limited to weddings. Your new marital status will be a factor when you file your taxes. For some couples, it means paying a higher tax bill. But others could see tax savings. More